Tackling the dominant global health problem — cardiovascular diseases

Insights, Portfolio

3rd April 2021

In the light of our investment in Vantis, to support them on your journey to improve cardiovascular disease treatments, our Principal Jan-Hendrik Bürk has written an article in which he explains why btov Partners invested in the startup from Munich, why we believe in the team and think that Vantis is taking the right approach.

Read the article here.

Press enter or esc to cancel